Advanced search
Publication Cover
Acta Cardiologica Volume 79, 2024 - Issue 3
Submit an article Journal homepage
155
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editors

Prompting ChatGPT to perform an umbrella review

Eleftherios Teperikidisa Third Department of Cardiology, Ippokratio General Hospital, Aristotle University of Thessa-loniki, Thessaloniki, Greece;b Clinical Research Unit, Special Unit for Biomedical Research and Education (SUBRE), School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceCorrespondence[email protected]
,
Aristi Boulmpoub Clinical Research Unit, Special Unit for Biomedical Research and Education (SUBRE), School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
&
Christodoulos Papadopoulosb Clinical Research Unit, Special Unit for Biomedical Research and Education (SUBRE), School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Pages 403-404 | Received 17 Jul 2023, Accepted 19 Jul 2023, Published online: 19 Sep 2023

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Amnuay Kleebayoon & Viroj Wiwanitkit. (2023) Long-term administration of proton pump inhibitors, risk of adverse cardiovascular outcomes? and ChatGPT: correspondence. Acta Cardiologica 0:0, pages 1-1.
Read now

Articles from other publishers (1)

David-Dimitris Chlorogiannis, Anastasios Apostolos, Anargyros Chlorogiannis, Leonidas Palaiodimos, George Giannakoulas, Sumant Pargaonkar, Sofia Xesfingi & Damianos G. Kokkinidis. (2023) The Role of ChatGPT in the Advancement of Diagnosis, Management, and Prognosis of Cardiovascular and Cerebrovascular Disease. Healthcare 11:21, pages 2906.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.